$Histogenics(OCGN)$Moving another step closer to World Health Organisation (WHO) approval, the rolling data of ‘made in India’ Covid-19 vaccine Covaxin will be starting in July. This has come after the pre-submission meeting held on June 23 with Bharat Biotech.The status of Covid-19 vaccines within the EUL/PQ (emergency use listing/prequalification) evaluation process was updated on Tuesday by WHO in its latest guidance document.Emergency Use Listing (EUL) is a procedure to streamline the process by which new or unlicensed products can be used during public health emergencies, WHO guidelines said.Stating that its Covid-19 vaccine Covaxin adheres to international standards, Bharat Biotech’s joint managing director Suchitra Ella on Tuesday said externa
$Histogenics(OCGN)$US FDA rejects emergency use approval for Bharat Biotech's Covaxin so down almost 30%.What will happen today? Will continue down?? Or up back to the previous value?
$BioNTech SE(BNTX)$TAIPEI: Terry Gou, the billionaire founder of Taiwan's Foxconn, and TSMC reached initial agreements to buy 5 million doses each of BioNTech SE's COVID-19 vaccine on Friday (Jul 2), three sources with knowledge of the situation told Reuters.Taiwan's government has tried for months to buy the shots directly from Germany's BioNTech and has blamed China, which claims the self-ruled island as its own territory, for nixing a deal the two sides were due to sign earlier this year.